Author: Abdullah, L; Awada, B; Kurban, M; Abbas, O
Title: Comment on 'Vitiligo in a COVID-19-vaccinated patient with ulcerative colitis: coincidence?': Type I interferons as possible link between COVID-19 vaccine and vitiligo Cord-id: jhs7g3i4 Document date: 2021_1_1
ID: jhs7g3i4
Snippet: We read with interest the article entitled "Vitiligo in a COVID-19-vaccinated patient with ulcerative colitis: coincidence?" by Aktas et al.1 The authors describe a 58-year-old man with ulcerative colitis who developed symmetrically distributed vitiligo facial patches around one week after receiving first dose of mRNA vaccine.1 the authors then ponder on the possible underlying immunological mechanism.
Document: We read with interest the article entitled "Vitiligo in a COVID-19-vaccinated patient with ulcerative colitis: coincidence?" by Aktas et al.1 The authors describe a 58-year-old man with ulcerative colitis who developed symmetrically distributed vitiligo facial patches around one week after receiving first dose of mRNA vaccine.1 the authors then ponder on the possible underlying immunological mechanism.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date